SEC Form 3
FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/24/2024 |
3. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 126,974(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (right to buy) | (2) | 08/06/2032 | Common Stock | 2,385 | 18.24 | D | |
Employee Stock Option (right to buy) | (3) | 04/06/2032 | Common Stock | 2,150 | 37.25 | D |
Explanation of Responses: |
1. Comprised of 7,341 shares of common stock and 119,633 shares of common stock represented by restricted stock units ("RSUs"). The RSUs consist of (1) 5,000 shares granted on November 6, 2021; (2) 7,150 shares granted on April 6, 2022; (3) 1,600 shares granted on August 6, 2022; (4) 11,655 shares granted on November 7, 2022; (5) 7,500 shares granted on April 6, 2023; (6) 10,000 shares granted on June 6, 2023; (7) 10,000 shares granted on July 6, 2023; and (8) 66,728 shares granted on February 1, 2024. Each of the foregoing RSU grants is subject to its own vesting schedule. |
2. The option was originally granted on August 6, 2022. 1/4th of the shares subject to the option vested on August 6, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter. |
3. The option was originally granted on April 6, 2022. 1/4th of the shares subject to the option vested on April 6, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter. |
Remarks: |
/s/ Jeffrey Adam Novack | 05/03/2024 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |